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Background: Immune-compromised patients incur a high risk of surgical wound dehiscence and colonization by
multidrug resistant organisms. Common treatment has been debridement and spontaneous secondary healing.
We report on the results obtained in nine such patients whose wounds were treated by debridement, negative
pressure dressing and direct closure.
Methods: All immune-compromised patients referred to our Institution between March 1, 2010 and November 30,
2011 for dehiscent abdominal wounds growing multidrug resistant organisms were treated by serial wound
debridements and negative pressure dressing. They were primarily closed, despite positive microbiological cultures,
when clinical appearance was satisfactory.
As a comparison, records from patients treated between March 1, 2008 and February 28, 2010 who, according to
our Institution’s policy at that time, had been left to heal by secondary intention, were retrieved and examined.
Results: Nine patients were treated by direct wound closure, five had been treated previously by secondary
intention healing.
Overall, ten patients had received liver transplant, 1 kidney transplant, 1 was HIV infected, 1 suffered from
multi-organ failure, 1 was undergoing hemodialysis.
Wound dehiscence involved skin and subcutaneous layers in all patients, in two the muscular layer was
also involved.
Mean healing time was significantly shorter in patients treated more recently by primary intention in comparison
with historical patients (28 vs 81 days). The only complication observed was a small superficial abscess that
developed around a non-absorbable stitch 10 months after closure in a patient treated by primary closure.
Conclusions: According to our results, fast healing can be safely obtained by closure of a clinically healthy wound,
despite growth of multidrug resistant organisms, even in immune-compromised patients.
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Critically ill and immune-compromised patients incur a
high risk of surgical wound infection and dehiscence. The
underlying disease and comorbidities such as foreign bod-
ies (abdominal mesh, suture material), serous collections
and devitalized tissues, all contribute to the risk of infec-
tion. In particular, bacterial infections contribute to the in-
creased morbidity and mortality of patients who have
undergone organ transplantation and are treated with im-
munosuppressive drugs and steroids [1-3].
Contamination and colonization of wounds by multidrug
resistant organisms (MDRO) is becoming more frequent
in the hospital setting, sometimes in the form of outbreaks,
as a consequence of aggressive immunosuppressive therap-
ies now available [4,5].
Because of the theoretical risk of systemic infection,
surgical wounds contaminated or colonized by MDRO
in immune-compromised patients have usually been
treated by partial debridement followed by spontaneous
secondary healing, although there are not, in the litera-
ture, solid data to support this practice.
On the basis of previously published data on successful
closure of contaminated wounds in immune-competent
patients [6,7], we hypothesized that such a procedureFigure 1 Examples of dehiscent abdominal wounds. (a) Dehiscent abd
transplantation. (b) Dehiscent abdominal wound colonized by Acinetobact
(c) Dehiscent abdominal wound colonized by Enterococcus faecium after l
Enterococcus faecium after liver transplantation. The Prolene mesh (Prolene
wall is clearly visible.could be applied without danger also in the wounds con-
taminated or colonized by MDRO of the immune-
compromised. In addition, negative pressure has been
shown to be a useful and safe adjunct to treatment in
difficult cases such as infected abdominal wounds, even
with exposed mesh [8,9].
We report here on the results obtained in nine immune-
compromised patients, whose dehiscent wounds, colonized
by MDRO, were treated by direct closure. As comparison
we examined the records of five patients that had been
treated in the past with the more conservative approach.
Methods
All the records of patients referred from March 1, 2008
to November 30, 2011 to the Plastic Surgery Unit of our
University Hospital for the treatment of open or dehis-
cent abdominal wounds were reviewed (Figure 1).
Only immune-compromised patients in whom micro-
biological wound cultures grew MDRO are included in
this report.
Patients presenting on or after March 1, 2010 were
treated by serial wound debridements (until healthy tis-
sue was reached), irrigation, and negative pressure dress-
ing (V.A.C.® Therapy, KCI UK Holdings Ltd.). Onceominal wound colonized by Acinetobacter baumannii after kidney
er baumannii after liver re-transplantation (due to Hepatitis B virus).
iver transplantation. (d) Dehiscent abdominal wound colonized by
™. Ethicon Inc., U.S.A.), used to bridge a missing part of the muscular
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were primarily closed, even in the presence of positive
microbiological cultures (Figure 2).
V.A.C. was applied with a negative pressure of 125 mm/
Hg, continuous mode, using the V.A.C.® GranuFoam™
dressings (black sponge), except in one case where the
V.A.C. GranuFoam Silver® was used), and changed every
3–4 days, according to the usual recommendations.
Because prior to March 1, 2010, it was our Institution’s
policy to treat contaminated or colonized wounds by de-
bridement and secondary intention healing, the data of pa-
tients so treated were retrieved and used as a comparison.
Microbiological cultures of specimens collected from
the wounds (swabs and tissue biopsies), were performed at
first presentation and then regularly every 4 to7 days, as is
the routine at our Institution, until healing was obtained.
Healing time, defined as complete skin closure, was
recorded from the first diagnosis of open wound or of
wound dehiscence. All wounds had healed before dis-
charge from the hospital. After discharge, follow-up of
patients of both groups was performed every two weeks
for the first two months.
Approval for the retrospective review of data was
obtained from the Department of Head and Neck Sur-
gery of the University Hospital of Modena.Figure 2 Phases of surgical treatment. Patient presenting with a dehisce
kidney transplant (a). Serial wound debridements (b, c). Negative pressure
appearance, with healthy granulating tissue despite still positive microbiolo
2 weeks post-operatively (g).Statistical analysis
Continuous data were reported as mean ± standard devi-
ation for the parameters with a normal distribution and
were compared using the two-sided Student’s t test or
the Mann–Whitney U test when appropriate. Compari-
sons between groups for categorical variables were car-
ried out using the χ-square test, with Yates’ correction,
or Fisher’s exact test when appropriate. The p-value of
0.05 or less was considered statistically significant. All
analyses were carried out using SPSS 19.0 for Windows
(SPSS, Chicago, IL).Results
Nine patients (6 male) of a average age of 53 ± 12.2 years
(range: 26–66) accessing our University Hospital on or
after March 1, 2010 were treated according to the proto-
col mentioned above. Average number of debridements
was 2.3 (range: 1 to 5).
Data from five patients treated before March 1, 2010,
of an average age of 51.2 ± 8.0 years (range: 42–64)
whose wound had been left to heal by secondary
intention were examined for comparison.
The two series of patients were not different in terms
of sex, age, etiology of immunodeficiency, size of thent abdominal wound colonized by Acinetobacter baumannii after
dressing (V.A.C. GranuFoam Silver®) positioned (d). Clinically satisfactory
gical cultures (e). Primary closure, 2 days post-operatively (f), and
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logic treatment (Table 1).
The abdominal wound dehiscence involved in all cases
the skin and subcutaneous layers, frequently showing an
unhealthy fascio-muscular layer. In two patients the
muscular layer was also open, causing continuity with
the abdominal cavity. In one of the two, part of the mus-
cular wall had been substituted with an exposed Prolene
mesh (Prolene ™. Ethicon Inc., U.S.A.), while in the other
patient severe edema due to an abdominal trauma and
partial colectomy prevented closure.
Microbiological cultures of the wounds showed growth
of multiresistant Acinetobacter baumannii (3 cases),
Enterococcus faecium (3 cases), Staphylococcus aureus
(1 case), Escherichia coli (1 case), Klebsiella pneumoniae
(1 case).
In all patients, at least in one phase of the admission
period, clinical signs of local infection appeared and sys-
temic cultures (either from blood, sputum, feces, urine,
mouth, skin or from all of these sites) were found to be
positive for the same bacteria colonizing the wound. In 1
of the 3 patients of the study group growing Acinetobacter
Baumanii in the wound, growth of the same bacteria was
found in sputum and feces at the moment of wound
closure and for 6 months at follow up without clinical
consequences or signs of infection (coltures were then
discontinued).
However, none of our patients showed clinical signs of
spreading invasive infection at the moment of final clos-
ure of the wound.
Antibiotics were always used, according to the suscep-
tibility test, for as long as the local and general condition
required.Table 1 Patients demographics
Sex (M/F) N





Wound size (cm2) Mean ± SD
Range





Present series: wound direct closure. Historical series: secondary intention healing.
The two groups were not statistically different in terms of sex, age, etiology of immAll the wounds treated by primary closure healed suc-
cessfully in a average time of 28.1 ± 6.8 days (range: 18
to 30) from the beginning of treatment. In 4 of the 5 pa-
tients whose wounds that had been left to heal by sec-
ondary intention healing had been obtained in 81.2 ±
11.9 days (range: 67 to 95). The remaining patient died
before the wound could heal, due to post-transplant
acute hepatitis C infection.
The difference in healing time between the two series
of patients was statistically significant (p = 0.002), per-
formed with the Mann–Whitney U test (Figure 3). Mean
follow-up was 16.1 ± 9.9 months (range: 3 to 29) for pa-
tients treated by primary closure.
The only complication observed among them was one
small abscess (7 mm× 4 mm) with sinus tract that devel-
oped on a closed wound, at the cranial extremity of the
xiphopubic scar, 10 months after surgery.
During surgical revision under local anesthesia, a non
adsorbable stitch was found in the abscess, that grew the
same Acinetobacter baumannii that had initially contam-
inated the wound, blood and airways. No further anti-
microbial treatment was necessary.
In the historic series of five patients left to heal by sec-
ondary intention no local or systemic complications re-
lated to the wound treatment were reported.Discussion
Multidrug-resistant bacteria are becoming increasingly
common as causative agents of nosocomial infections and
their antimicrobial resistance is also increasing, limiting
pharmacological treatment options [10,11]. Acinetobacter
baumannii, Klebsiella Pneumoniae, Staphylococcus aureusPresent series Historical series
(9 patients) (5 patients)
6/3 3/2












unodeficiency, size of the wounds, bacterial colonizing agents.
Figure 3 Healing time in the case series treated by primary closure (serial debridment, negative pressure dressing, surgical closure of
the wound) compared with healing time of wounds left to heal by secondary intention. The difference is statistically significant (p = 0.002).
The statistical analysis was performed with the Mann–Whitney U test.
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nia, meningitis, urinary tract and wound infection.
Risk factors for colonization or infection with multidrug-
resistant species include prolonged length of hospital stay,
admission to intensive care unit, mechanical ventilation,
exposure to antimicrobial agents, recent surgery, invasive
procedures, and severity of underlying illness [12,13].
Patients infected with these organisms are often debili-
tated, a fact that explains the high mortality and mor-
bidity observed [14].
Several studies have been published on the subject of
wounds contaminated or infected by MDRO, both in the
population at large and in the military, whose wounds
are a consequence of traumatic war injuries [14-17].
Similarly to other contaminated or infected wounds,
mechanical debridement, that removes the non-viable
tissue, is essential in reducing the bacterial load and
eradicating the wound biofilm [18]. Leaving contami-
nated wounds to heal spontaneously by secondary
intention has been demonstrated to be safe [7], but it re-
quires a long healing time and frequent and time-
consuming changing of wound dressings. Moreover, an
open wound could become further infected and create
severe problems of metabolic balance in already severely
ill patients. Direct closure of such wounds presents
therefore several advantages.
Although the safety of directly closing a contami-
nated wound has been shown in immune-competent
patients [6,7,19,20], to the best of our knowledge, safetyof primary MDRO-contaminated wound closure in im-
mune-compromised patients has not yet been reported.
The difference in mean healing time in patients whose
wounds were closed directly (28 days) when compared
with patients whose wounds in the past were left to heal
by secondary intention (81 days) was clinically relevant.
A shorter time of regular dressing changes means less
pain and discomfort and, potentially, shorter hospi-
talization time.
Unfortunately, length of hospital stay and related costs
of the two treatment protocols could not be compared
due to multiple confounding factors. In particular, the
length of hospital stay was influenced more by the under-
lying condition than by the delayed wound healing.
The encouraging results obtained in our (admittedly
few) patients suggest that clinically healthy wounds can be
closed, without severe adverse effects, also in immune-
compromised patients despite the persistence of MDRO
positive microbiological cultures.
However a few notes of caution are necessary. None of
our patients showed signs of spreading invasive infection at
the moment of final closure of the wound. In fact, while
direct surgical closure can induce stable healing by primary
intention in case of simple contamination (presence of
non-replicating organisms), colonization (replicating micro-
organisms without tissue damage), or critical colonization
(unhealthy granulation, no clinical signs of infection except
delayed healing), surgical closure may not be safe in
wounds with spreading invasive infection i.e. replicating
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ical judgment of the appearance of the wound is also
needed. In general, healthy, vascularised tissue should be
visible on the wound surface before surgical closure is
performed [21].
The role of negative pressure dressing in reducing the
bacterial load while improving vascularisation and anti-
biotic delivery has been demonstrated [8,21].
In our patients, after the use of negative pressure
dressings, improved perfusion, reduced secretions and
debris of the fascial plane of the wound were observed,
suggesting readiness for direct surgical closure.
A randomized study would be desirable, although crit-
ically ill, immune-compromised patients, presenting with
dehiscent surgical abdominal wounds that grow MDRO
are relatively rare.
In addition, given the excellent results obtained with
the first few patients treated by primary closure, one
wonders if leaving patients to heal by secondary in-
tention would be ethically acceptable.
Conclusions
Our experience, albeit small, suggests that closure of a
clinically healthy wound is feasible, despite microbio-
logical swabs positive for MDRO, even in a population
of critically ill, immune-compromised patients. Serial de-
bridement, negative pressure dressing, and direct surgi-
cal closure can lead to durable healing in a shorter time
than that required by secondary intention healing.
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